FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to ophthalmology, and can be applied in therapy for ocular neuropathy or optic nerve in human or animal. In such cases preparation is injected into the eye vitreous body, containing effective amount of urea or urea derivatives. The application of urea or its derivatives is also proposed in preparation of stabilized water solutions for injection into vitreous body.
EFFECT: exclusion of vitreoretinal traction, and allowing separation of retina inner boundary membrane from vitreous body cortical part, due to liquefaction of vitreous body endolymph.
19 cl, 5 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR INTRODUCING INTO VITREOUS BODY FOR TREATING OR PREVENTING OPHTHALMIC DISEASES | 2000 |
|
RU2286157C2 |
| METHOD OF NAVIGATION LASER TREATMENT OF RHEGMATOGENOUS PERIPHERAL RETINAL DEGENERATIONS (EMBODIMENTS) | 2023 |
|
RU2812202C1 |
| METHOD OF PERIPHERAL RETINAL RUPTURES TREATMENT COMPLICATED WITH VITREAL TRACTION AND SUBCLINICAL RETINAL DETACHMENT | 2006 |
|
RU2325884C2 |
| METHOD FOR PREVENTION OF MACULAR RUPTURE IN PATIENTS WITH VITREOMACULAR TRACTION SYNDROME 1A-1B STAGE IN PRESENCE OF A MACULAR RUPTURE IN THE PAIRED EYE | 2018 |
|
RU2676606C1 |
| APPLICATION OF ANTAGONIST VEGF IN TREATMENT OF CHORIORETINAL NEOVASCULAR DISTURBANCES AND DISORDERS OF PENETRATION IN PEDIATRIC PATIENTS | 2014 |
|
RU2676274C2 |
| METHOD FOR COMBINED LASER TREATMENT OF VALVE RETINAL RUPTURES WITH VITREORETINAL ADHESION ON ENTIRE AREA OF RETINAL VALVE | 2016 |
|
RU2625778C1 |
| INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF | 2012 |
|
RU2721907C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
| METHOD FOR SURGICAL MANAGEMENT OF MACULAR OEDEMA FOLLOWING CATARACT PHACOEMULSIFICATION | 2010 |
|
RU2453297C2 |
| RETINOSCHISIS TREATMENT METHOD | 2019 |
|
RU2735347C1 |
